FADD at the Crossroads between Cancer and Inflammation - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Trends in Immunology Année : 2018

FADD at the Crossroads between Cancer and Inflammation

Résumé

Initially described as an adaptor molecule for death receptor (DR)-mediated apoptosis, Fas-associated death domain (FADD) was later implicated in nonapoptotic cellular processes. During the last decade, FADD has been shown to participate and regulate most of the signalosome complexes, including necrosome, FADDosome, innateosome, and inflammasome. Given the role of these signaling complexes, FADD has emerged as a new actor in innate immunity, inflammation, and cancer development. Concomitant to these new roles, a surprising number of mechanisms deemed to regulate FADD functions have been identified, including post-translational modifications of FADD protein and FADD secretion. This review focuses on recent knowledge of the biological roles of FADD, a pleiotropic molecule having multiple partners, and its impact in cancer, innate immunity, and inflammation.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03971710 , version 1 (03-02-2023)

Identifiants

Citer

Sara Mouasni, Léa Tourneur. FADD at the Crossroads between Cancer and Inflammation. Trends in Immunology, 2018, 39 (12), pp.1036-1053. ⟨10.1016/j.it.2018.10.005⟩. ⟨inserm-03971710⟩
10 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More